Amid sudden global spike in COVID cases, Union health minister Mansukh Mandaviya on Thursday reviewed the status, adequacy of COVID management drugs and production capacities with representatives of pharma companies through a VC, here today.
The virtual meeting was held to effectively handle any situation arises in view of the spike in COVID19 cases in some countries worldwide.
Through a presentation, the Union Minister was briefed regarding the evolving global scenario. “India’s pharmaceutical industry is robust, resilient and responsive. It is due to their strength that we could not only meet our down demand during the pandemic, but also be in a position to supply medicines to 150 countries”, Mandaviya said.
He stressed that it has been achieved without any fall in quality and no hike in the price of the medicines. The pharma companies were asked to keep a close watch on the global supply chain scenario. They were also asked to closely monitor production and availability of APIs as well as formulations of essential medicines for COVID management.
The health minister asked the Pharma company to ensure adequate stocks and availability of all drugs including COVID drugs in the supply chain up to the retail level. The pharma companies hailed the timely review meeting and assured their continued support.
The Pharma company assured to manage the supply chain of COVID drugs.
Recognizing the increasing burden of non-communicable diseases (NCDs) and the pivotal role of improving understanding…
The BJP-led Delhi government on Saturday entered into an agreement with the Union health ministry…
In a one of its kind research, India is set to begin an inter-ministerial scientific…
As an ode to Dr. Samuel Hahnemann, the founder of homoeopathy, on his birth-anniversary on…
RJD president and former Bihar chief minister Lalu Prasad was on Wednesday taken to Delhi…
The Indian Society for Extracellular Vesicles (InSEV) successfully hosted its inaugural conference, EVOLVE 2025, from…